STOCK TITAN
  1. Home
  2. SEC Filings
  3. PVLA
  4. [Form 4] PALVELLA THERAPEUTICS, INC. Insider Trading Activity

Palvella Therapeutics director sells 27,500 shares

Palvella Therapeutics, Inc. director George M. Jenkins directly sold 27,500 shares of common stock in transactions on October 12, 2026, October 13, 2026, and October 14, 2026, under a Rule 10b5-1 trading plan adopted on June 12, 2026.

Filing Impact
(High)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Palvella Therapeutics, Inc. director George M. Jenkins directly sold 27,500 shares of common stock in transactions on October 12, 2026, October 13, 2026, and October 14, 2026, under a Rule 10b5-1 trading plan adopted on June 12, 2026. Reported weighted-average prices included $132.6165 per share for 5,095 shares sold October 12, 2026, $128.5206 per share for 2,004 shares sold October 13, 2026, and $121.1403 per share for 476 shares sold October 14, 2026.

Insights

Analyzing...

Insider JENKINS GEORGE M
Role Director
Sold 27,500 shs ($3.58M)
Type Security Shares Price Value
Sale Common Stock F1, F13 476 $121.1403 $58K
Sale Common Stock F1, F14 2,072 $122.6151 $254K
Sale Common Stock F1, F15 2,604 $123.2896 $321K
Sale Common Stock F1, F16 920 $124.3652 $114K
Sale Common Stock F1, F17 597 $125.3271 $75K
Sale Common Stock F1, F18 505 $126.5548 $64K
Sale Common Stock F1, F7 2,004 $128.5206 $258K
Sale Common Stock F1, F8 1,644 $129.2305 $212K
Sale Common Stock F1, F9 990 $130.4802 $129K
Sale Common Stock F1, F10 1,035 $131.49 $136K
Sale Common Stock F1, F11 579 $132.4046 $77K
Sale Common Stock F1, F12 922 $133.7227 $123K
Sale Common Stock F1, F2 5,095 $132.6165 $676K
Sale Common Stock F1, F3 2,458 $133.2483 $328K
Sale Common Stock F1, F4 3,335 $134.2086 $448K
Sale Common Stock F1, F5 1,447 $135.4968 $196K
Sale Common Stock F1, F6 817 $136.4444 $111K
holding Common Stock F19 -- -- --
Holdings After Transaction: Common Stock — 132,616 shares (Direct); Common Stock — 13,516 shares (Indirect, By foundation)
Footnotes (19)
  1. F1. The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons.
  2. F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.91 to $132.9064, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.91 to $133.9078, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.9184 to $134.9182, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.9283 to $135.8712, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  6. F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.9387 to $136.8346, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  7. F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.91 to $128.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  8. F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.915 to $129.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  9. F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.00 to $130.855, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  10. F10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.07 to $132.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  11. F11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.07 to $133.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  12. F12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.11 to $134.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  13. F13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.7075 to $121.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  14. F14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $121.90 to $122.8795, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  15. F15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.903 to $123.8032, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  16. F16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.91 to $124.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  17. F17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.99 to $125.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  18. F18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.13 to $127.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  19. F19. Eagles Mere Air Museum Foundation.
Common shares sold 27,500 shares Direct sales on October 12, 2026, October 13, 2026, and October 14, 2026
Weighted-average sale price $132.6165 per share 5,095 shares sold on October 12, 2026
Weighted-average sale price $128.5206 per share 2,004 shares sold on October 13, 2026
Weighted-average sale price $121.1403 per share 476 shares sold on October 14, 2026
Indirect common shares held 13,516 shares Eagles Mere Air Museum Foundation, October 12, 2026
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
material non-public information regulatory
"not in possession of material non-public information"
Material non-public information is important news about a company that hasn't been shared with the public yet, like a secret that could affect its stock price. Using this inside information to buy or sell stocks is unfair and illegal because it gives someone an unfair advantage over others who don’t have the same info.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PVLA shares did director George M. Jenkins sell?
George M. Jenkins, a director of Palvella Therapeutics, directly sold 27,500 shares of common stock on October 12, 2026, October 13, 2026, and October 14, 2026. The sales were made under a Rule 10b5-1 trading plan.

Was George M. Jenkins's PVLA sale made under a trading plan?
Yes. The sales were made under a Rule 10b5-1 trading plan adopted on June 12, 2026, during an open trading window. Jenkins was not in possession of material non-public information, and the plan was reviewed and approved under Palvella's Insider Trading Policy.

How many PVLA shares are held by Eagles Mere Air Museum Foundation?
Eagles Mere Air Museum Foundation was reported as indirectly holding 13,516 shares of Palvella common stock on October 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JENKINS GEORGE M
(Last)(First)(Middle)
C/O PALVELLA THERAPEUTICS, INC.
353 W. LANCASTER AVENUE, SUITE 200
(Street)
WAYNE PENNSYLVANIA 19087
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
PALVELLA THERAPEUTICS, INC. [ PVLA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/12/2026S(1)5,095D$132.6165(2)155,021D
Common Stock10/12/2026S(1)2,458D$133.2483(3)152,563D
Common Stock10/12/2026S(1)3,335D$134.2086(4)149,228D
Common Stock10/12/2026S(1)1,447D$135.4968(5)147,781D
Common Stock10/12/2026S(1)817D$136.4444(6)146,964D
Common Stock10/13/2026S(1)2,004D$128.5206(7)144,960D
Common Stock10/13/2026S(1)1,644D$129.2305(8)143,316D
Common Stock10/13/2026S(1)990D$130.4802(9)142,326D
Common Stock10/13/2026S(1)1,035D$131.49(10)141,291D
Common Stock10/13/2026S(1)579D$132.4046(11)140,712D
Common Stock10/13/2026S(1)922D$133.7227(12)139,790D
Common Stock10/14/2026S(1)476D$121.1403(13)139,314D
Common Stock10/14/2026S(1)2,072D$122.6151(14)137,242D
Common Stock10/14/2026S(1)2,604D$123.2896(15)134,638D
Common Stock10/14/2026S(1)920D$124.3652(16)133,718D
Common Stock10/14/2026S(1)597D$125.3271(17)133,121D
Common Stock10/14/2026S(1)505D$126.5548(18)132,616D
Common Stock13,516IBy foundation(19)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.91 to $132.9064, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.91 to $133.9078, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.9184 to $134.9182, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.9283 to $135.8712, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.9387 to $136.8346, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.91 to $128.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.915 to $129.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.00 to $130.855, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.07 to $132.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.07 to $133.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.11 to $134.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.7075 to $121.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $121.90 to $122.8795, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.903 to $123.8032, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.91 to $124.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.99 to $125.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.13 to $127.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
19. Eagles Mere Air Museum Foundation.
/s/ Kathleen A. McGowan, Attorney-in-Fact10/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on PVLA

All PVLA news

Trending in the feed

ACB
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside Open the live feed